Baby Friendly Hospitals – The experiene of Norway, 1999

The purpose of the project is to map the implementation of the Mother-Child-Friendly Initiative (MBVI), by comparing the responses of the new mothers and responses from the hospitals. The data set thus consists of two files - one from mothers and from the hospitals. MBVI was implemented in Norwegian hospitals during the period 1993-1996. The main features of the survey is to examine breastfeeding guidance and monitoring of mothers at Norwegian maternity wards. MBVI aims to facilitate successful breastfeeding. The survey shows that there is an significant improvement in both health care routines and breastfeeding guidance, since the project's start-up in 1993. The project can be interpreted together with the WHO / UNICEF project "Evidence for the ten steps to successful breastfeeding"

Topical treatment with fresh human milk versus emollient on atopic eczema spots in young children: a small, randomized, split body, controlled, blinded pilot study

Background Public health nurses report on effects of fresh human milk as treatment for conjunctivitis, rhinitis and atopic eczema (AE), the latter being highly prevalent in early childhood. Emollients and topical corticosteroids are first line treatment of AE. As many caregivers have steroid phobia, alternative treatment options for mild AE are of interest. The aim of this small pilot study was to assess the potential effects and risks of applying fresh human milk locally on eczema spots in children with AE. Methods This was a split body, controlled, randomized and physician blinded pilot study, of children with AE with two similar contralateral eczema spots having a mother breastfeeding the child or a sibling. Fresh expressed milk and emollient was applied on the intervention spot and emollient alone on the control area, three times a day for four weeks. The severity and area of the eczema spots was evaluated weekly, and samples from milk and the spots were analysed weekly with respect to bacterial colonisation. Results Of nine patients included, six completed the study. Mean age at inclusion was 18.5 months. The spots examined were localized on the arms, legs or cheeks. The spots were similar in severity, but differed in area. In one patient the eczema ceased after inclusion. In four patients both control and intervention areas increased during the intervention. The relative change in eczema area compared to baseline showed less increase in the intervention spots in two patients, whereas the opposite was observed in three. In four children Staphylococcus aureus was found in their eczema once or more. In three of the 28 human milk samples, Staphylococcus aureus, alfa haemolytic streptococci or coagulase negative staphylococci were detected. Staphylococcus aureus was found once both in human milk and in the eczema spots, no clinical signs of infection were however observed. No secondary infection due to milk application was detected. Conclusion In this small pilot study, no effect was found on eczema spots treated with topical application of fresh human milk. (ClinicalTrials.gov Identifier, NCT02381028 )

Er legerollen uforenlig med dødshjelp?

Source at https://www.fagbokforlaget.no/Verk/Tidsskrift-Omsorg.En problemstilling idødshjelpsdeba en er hvordan dødshjelp kan forenes etisk med rollen som helsepersonell, og spesielt med rollen som behandlende lege. Andelen leger som stø er legalisering av dødshjelp er økende, og en prosess for åavklare legens mulige oppgaver ved livets slu er derfor betimelig. Legeyrket innebærer ere faglige roller, en av dem er åvære sakkyndig. Vi skisserer en hypotetisk modell som viser hvordan legens roller som behandler og sakkyndig kan forenes med dødshjelp. Vi argumenterer for at de medisinskfaglige vurderingene ved dødshjelp ikke nødvendigvis vil være vesentlig annerledes enn vurderinger som aksepteres iklinisk praksis idag